Structure and function of adenosine receptor heteromers.


Journal

Cellular and molecular life sciences : CMLS
ISSN: 1420-9071
Titre abrégé: Cell Mol Life Sci
Pays: Switzerland
ID NLM: 9705402

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 31 07 2020
accepted: 15 01 2021
revised: 07 01 2021
pubmed: 14 2 2021
medline: 20 5 2021
entrez: 13 2 2021
Statut: ppublish

Résumé

Adenosine is one of the most ancient signaling molecules and has receptors in both animals and plants. In mammals there are four specific receptors, A

Identifiants

pubmed: 33580270
doi: 10.1007/s00018-021-03761-6
pii: 10.1007/s00018-021-03761-6
doi:

Substances chimiques

Receptors, Purinergic P1 0
Adenosine K72T3FS567

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3957-3968

Subventions

Organisme : Ministerio de Economía y Competitividad (ES)
ID : SAF2017-84117
Organisme : Secretaría de Estado de Investigación, Desarrollo e Innovación
ID : RTI2018-098830-B-I00

Références

Burnstock G, Verkhratsky A (2009) Evolutionary origins of the purinergic signalling system [Internet]. Acta Physiol 195:415–447. https://doi.org/10.1111/j.1748-1716.2009.01957.x ((Wiley))
doi: 10.1111/j.1748-1716.2009.01957.x
Alexander SP, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD et al (2017) The concise guide to pharmacology overview. Br J Pharmacol [Internet] 174:S1-16. https://doi.org/10.1111/bph.13882
doi: 10.1111/bph.13882
Daly JW, Butts-Lamb P, Padgett W (1983) Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines. Cell Mol Neurobiol [Internet] 3(1):69–80. https://doi.org/10.1007/BF00734999
doi: 10.1007/BF00734999
Fredholm BB, Irenius E, Kull B, Schulte G (2001) Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol 61(4):443–448
doi: 10.1016/S0006-2952(00)00570-0
Alnouri MW, Jepards S, Casari A, Schiedel AC, Hinz S, Müller CE (2015) Selectivity is species-dependent: characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors. Purinergic Signal 11(3):389–407. https://doi.org/10.1007/s11302-015-9460-9
doi: 10.1007/s11302-015-9460-9 pubmed: 26126429 pmcid: 4529847
Hinz S, Alnouri WM, Pleiss U, Müller CE (2018) Tritium-labeled agonists as tools for studying adenosine A 2B receptors. Purinergic Signal [Internet]. 14(3):223–233. https://doi.org/10.1007/s11302-018-9608-5
doi: 10.1007/s11302-018-9608-5 pubmed: 29752618 pmcid: 6107469
Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB et al (1997) Comparative pharmacology of human adenosine receptor subtypes—characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol [Internet] 357(1):1–9. https://doi.org/10.1007/PL00005131
doi: 10.1007/PL00005131
Frohman MA, Dush MK, Martin GR (1988) Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci U S A [Internet]. 85(23):8998–9002. Available from: https://pubmed.ncbi.nlm.nih.gov/2461560/
Libert F, Parmentier M, Lefort A, Dinsart C, Van Sande J, Maenhaut C, et al. (1989) Selective amplification and cloning of four new members of the G protein-coupled receptor family. Science [Internet]. 244(4904):569–72. Available from: https://science.sciencemag.org/content/244/4904/569
Jaakola V-P, Griffith MT, Hanson MA, Cherezov V, Chien EYT, Lane JR, et al. (2008) The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science [Internet]. 322(5905):1211–7. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2586971&tool=pmcentrez&rendertype=abstract
Pándy-Szekeres G, Munk C, Tsonkov TM, Mordalski S, Harpsøe K, Hauser AS, et al. (2018) GPCRdb in 2018: Adding GPCR structure models and ligands. Nucleic Acids Res [Internet]. 46(D1):D440–6. Available from: https://pubmed.ncbi.nlm.nih.gov/29155946/
Glukhova A, Thal DM, Nguyen AT, Vecchio EA, Jörg M, Scammells PJ, et al. (2017) Structure of the adenosine A1 receptor reveals the basis for subtype selectivity. Cell [Internet]. 168(5):867–877.e13. Available from: https://pubmed.ncbi.nlm.nih.gov/28235198/
Jespers W, Schiedel AC, Heitman LH, Cooke RM, Kleene L, van Westen GJP, et al. (2018) Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms [Internet]. Trends Pharmacol Sci. 39: 75–89. Available from: https://pubmed.ncbi.nlm.nih.gov/29203139/
Drury AN, Szent-Györgyi A (1929) The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol [Internet]. 68(3):213–37. Available from: https://pubmed.ncbi.nlm.nih.gov/16994064/
Wolf MM, Berne RM (1956) Coronary vasodilator properties of purine and pyrimidine derivatives. Circ Res [Internet]. 4(3):343–348. https://doi.org/10.1161/01.RES.4.3.343
doi: 10.1161/01.RES.4.3.343 pubmed: 13317030
Buckley NM, Tsuboi KK, Zeig NJ (1959) Effect of nucleosides on acute left ventricular failure in the isolated dog heart. Circ Res [Internet] 7(6):847–857. https://doi.org/10.1161/01.RES.7.6.847
doi: 10.1161/01.RES.7.6.847
Agnati LF, Fuxe K, Ferri M, Benfenati F, Ogren SO (1981) A new hypothesis on memory—a possible role of local circuits in the formation of the memory trace. Med Biol [Internet]. 59(4):224–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7339294
Fuxe K, Agnati LF (1985) Receptor–receptor interactions in the central nervous system. A new integrative mechanism in synapses. Med Res Rev [Internet]. 5(4):441–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2999530
Fuxe K, Agnati LF, Benfenati F, Cimmino M, Algeri S, Hökfelt T, et al. (1981) Modulation by cholecystokinins of 3 H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites. Acta Physiol Scand [Internet]. 113(4):567–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6291324
Agnati LF, Fuxe K, Zoli M, Rondanini C, Ogren SO (1982) New vistas on synaptic plasticity: the receptor mosaic hypothesis of the engram. Med Biol [Internet]. 60(4):183–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6128444
Fuxe K, Härfstrand A, Agnati LF, Kalia M, Fredholm B, Svensson T, et al. (1987) Central catecholamine–neuropeptide Y interactions at the pre- and postsynaptic level in cardiovascular centers. J Cardiovasc Pharmacol [Internet]. 10 (Suppl 1):S1–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2455156
Fuxe K, Agnati LF, Benfenati F, Celani M, Zini I, Zoli M, et al. (1983) Evidence for the existence of receptor–receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides. J Neural Transm Suppl [Internet]. 18:165–79. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6192208
García-Recio A, Navarro G, Franco R, Olivella M, Guixà-González R, Cordomí A (2020) DIMERBOW: exploring possible GPCR dimer interfaces. Bioinformatics [Internet]. Available from: http://lmc.uab.es/dimerbow/ .
Wu B, Chien EYT, Mol CD, Fenalti G, Liu W, Katritch V, et al. (2010) Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science (80) [Internet]. 330(6007):1066–71. Available from: https://pubmed.ncbi.nlm.nih.gov/20929726/
Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, et al. (2012) Crystal structure of the µ-opioid receptor bound to a morphinan antagonist. Nature [Internet]. 485(7398):321–6. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3523197&tool=pmcentrez&rendertype=abstract
Huang J, Chen S, Zhang JJ, Huang X-Y, Whorton MR, Bokoch MP, et al. (2013) Crystal structure of oligomeric β1-adrenergic G protein-coupled receptors in ligand-free basal state. Nat Struct Mol Biol [Internet]. 20(4):419–25. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3618578&tool=pmcentrez&rendertype=abstract
Koehl A, Hu H, Feng D, Sun B, Zhang Y, Robertson MJ, et al. (2019) Structural insights into the activation of metabotropic glutamate receptors. Nature [Internet]. 566(7742):79–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30675062
Duthey B, Caudron S, Perroy J, Bettler B, Fagni L, Pin J-P, et al. (2002) A single subunit (GB2) is required for G-protein activation by the heterodimeric GABA
Doumazane E, Scholler P, Zwier JM, Trinquet E, Rondard P, Pin J-PJ (2011) A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors. FASEB J [Internet]. 25(1):66–77. Available from: https://pubmed.ncbi.nlm.nih.gov/20826542/
Rasmussen SGFF, Devree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS et al (2011) Crystal structure of the β 2 adrenergic receptor–Gs protein complex. Nature 477(7366):549–557
doi: 10.1038/nature10361
Navarro G, Gonzalez A, Campanacci S, Rivas-Santisteban R, Reyes-Resina I, Casajuana-Martin N, et al. (2020) Experimental and computational analysis of biased agonism on full-length and a C-terminally truncated adenosine A2A receptor. Comput Struct Biotechnol J [Internet]. 18:2723–32. Available from: https://pubmed.ncbi.nlm.nih.gov/33101610/
Draper-Joyce CJ, Khoshouei M, Thal DM, Liang YL, Nguyen ATN, Furness SGB, et al. (2018) Structure of the adenosine-bound human adenosine A1 receptor–Gi complex. Nature [Internet]. 558(7711):559–65. Available from: https://pubmed.ncbi.nlm.nih.gov/29925945/
Carpenter B, Nehmé R, Warne T, Leslie AGW, Tate CG (2016) Structure of the adenosine A2A receptor bound to an engineered G protein. Nature [Internet]. 536(7614):104–7. Available from: https://pubmed.ncbi.nlm.nih.gov/27462812/
García-Nafría J, Lee Y, Bai X, Carpenter B, Tate CG (2018) Cryo-EM structure of the adenosine A2A receptor coupled to an engineered heterotrimeric G protein. Elife [Internet]. 7:e35946. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29726815
Viñals X, Moreno E, Lanfumey L, Cordomí A, Pastor A, de La Torre R, et al. (2015) Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. PLoS Biol [Internet]. 13(7):e1002194. Available from: https://pubmed.ncbi.nlm.nih.gov/26158621/
Guinart D, Moreno E, Galindo L, Cuenca-Royo A, Barrera-Conde M, Pérez EJ, et al. (2020) Altered signaling in CB1R-5-HT2AR heteromers in olfactory neuroepithelium cells of schizophrenia patients is modulated by cannabis use. Schizophr Bull [Internet]. Available from: https://pubmed.ncbi.nlm.nih.gov/32249318/
Cordomí A, Navarro G, Aymerich MS, Franco R (2015) Structures for G-protein-coupled receptor tetramers in complex with G proteins. Trends Biochem Sci [Internet] 40(10):548–51. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0968000415001280
Navarro G, Ferré S, Cordomi A, Moreno E, Mallol J, Casadó V, et al. (2010) Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers. J Biol Chem [Internet]. 285(35):27346–59. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20562103
Köfalvi A, Moreno E, Cordomí A, Cai NS, Fernández-Dueñas V, Ferreira SG, et al. (2020) Control of glutamate release by complexes of adenosine and cannabinoid receptors. BMC Biol [Internet]. 18(1). Available from: https://pubmed.ncbi.nlm.nih.gov/31973708/
Whorton MR, Bokoch MP, Rasmussen SGF, Huang B, Zare RN, Kobilka B et al (2007) A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc Natl Acad Sci USA 104(18):7682–7687
doi: 10.1073/pnas.0611448104
Navarro G, Cordomí A, Brugarolas M, Moreno E, Aguinaga D, Pérez-Benito L et al (2018) Cross-communication between Gi and Gs in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain. BMC Biol [Internet] 24(1):1–15. https://doi.org/10.1186/s12915-018-0491-x
doi: 10.1186/s12915-018-0491-x
Navarro G, Cordomí A, Zelman-Femiak M, Brugarolas M, Moreno E, Aguinaga D et al (2016) Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs. BMC Biol [Internet] 14(1):26. https://doi.org/10.1186/s12915-016-0247-4
doi: 10.1186/s12915-016-0247-4
Alexander SP, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA et al (2019) The concise guide to pharmacology 2019/20: G protein-coupled receptors. Br J Pharmacol 1(176):S21-141
Borroto-Escuela DO, Brito I, Romero-Fernandez W, Di Palma M, Oflijan J, Skieterska K, et al. (2014) The G protein-coupled receptor heterodimer network (GPCR-HetNet) and its hub components. Int J Mol Sci [Internet]. 15(5):8570–90. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4057749&tool=pmcentrez&rendertype=abstract
Gomes I, Ayoub MA, Fujita W, Jaeger WC, Pfleger KDG, Devi LA (2016) G protein-coupled receptor heteromers. Annu Rev Pharmacol Toxicol [Internet] 56(1):403–425. https://doi.org/10.1146/annurev-pharmtox-011613-135952
doi: 10.1146/annurev-pharmtox-011613-135952
Carriba P, Navarro G, Ciruela F, Ferré S, Casadó V, Agnati L, et al. (2008) Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat Methods [Internet]. 5(8):727–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18587404
Canals M, Burgueño J, Marcellino D, Cabello N, Canela EI, Mallol J et al (2004) Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Neurochem 88(3):726–734
doi: 10.1046/j.1471-4159.2003.02200.x
Patowary S, Alvarez-Curto E, Xu TR, Holz JD, Oliver JA, Milligan G, et al. (2013) The muscarinic M3 acetylcholine receptor exists as two differently sized complexes at the plasma membrane. Biochem J [Internet]. 452(2):303–12. Available from: https://portlandpress.com/biochemj/article-pdf/452/2/303/676044/bj4520303.pdf
Gilchrist A, Li A, Hamm HE (2002) Design and use of C-terminal minigene vectors for studying role of heterotrimeric G proteins. In: Methods in Enzymology [Internet]. Academic Press Inc. p. 58–69. Available from: https://pubmed.ncbi.nlm.nih.gov/11771412/
Gilchrist A, Li A, Hamm H (2002) G alpha COOH-terminal minigene vectors dissect heterotrimeric G protein signaling. Sci STKE [Internet]. Available from: https://pubmed.ncbi.nlm.nih.gov/11836477/
Guidotti G, Brambilla L, Rossi D (2017) Cell-Penetrating peptides: from basic research to clinics [Internet]. Vol. 38, Trends in pharmacological sciences. Elsevier Ltd; p. 406–24. Available from: https://pubmed.ncbi.nlm.nih.gov/28209404/
Milletti F (2012) Cell-penetrating peptides: classes, origin, and current landscape [Internet]. Vol. 17, Drug discovery today. Drug Discov Today. p. 850–60. Available from: https://pubmed.ncbi.nlm.nih.gov/22465171/
Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science (80) [Internet]. 285(5433):1569–72. Available from: https://pubmed.ncbi.nlm.nih.gov/10477521/
He SQ, Zhang ZN, Guan JS, Liu HR, Zhao B, Wang HB, et al. (2011) Facilitation of μ-Opioid Receptor Activity by Preventing δ-Opioid Receptor-Mediated Codegradation. Neuron [Internet]. 69(1):120–31. Available from: https://pubmed.ncbi.nlm.nih.gov/21220103/
Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA (2000) Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J Neurosci [Internet]. 20(22):RC110. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3125672&tool=pmcentrez&rendertype=abstract
Jastrzebska B, Chen Y, Orban T, Jin H, Hofmann L, Palczewski K (2015) Disruption of rhodopsin dimerization with synthetic peptides targeting an interaction interface. J Biol Chem [Internet] 290(42):25728–25744. https://doi.org/10.1074/jbc.M115.662684
doi: 10.1074/jbc.M115.662684
Gnad T, Navarro G, Lahesmaa M, Reverte-Salisa L, Copperi F, Cordomi A, et al. (2020) Adenosine/A2B receptor signaling ameliorates the effects of aging and counteracts obesity. Cell Metab [Internet]. 32(1). Available from: https://pubmed.ncbi.nlm.nih.gov/32589947/
Guo W, Urizar E, Kralikova M, Mobarec JC, Shi L, Filizola M et al (2008) Dopamine D2 receptors form higher order oligomers at physiological expression levels. EMBO J [Internet] 27(17):2293–2304. https://doi.org/10.1038/emboj.2008.153
doi: 10.1038/emboj.2008.153
Xue L, Rovira X, Scholler P, Zhao H, Liu J, Pin J-P, et al. (2014) Major ligand-induced rearrangement of the heptahelical domain interface in a GPCR dimer. Nat Chem Biol [Internet]. 11(2):134–40. Available from: http://www.nature.com/articles/nchembio.1711
Caltabiano G, Gonzalez A, Cordomí A, Campillo M, Pardo L (2013) The role of hydrophobic amino acids in the structure and function of the rhodopsin family of G protein-coupled receptors. In: Methods in Enzymology [Internet]. Academic Press Inc.; p. 99–115. Available from: https://pubmed.ncbi.nlm.nih.gov/23332697/
Olivella M, Caltabiano G, Cordomí A (2013) The role of Cysteine 6.47 in class A GPCRs. BMC Struct Biol [Internet]. Available from: https://pubmed.ncbi.nlm.nih.gov/23497259/
Ciruela F, Casadó V, Rodrigues R, Luján R, Burgueño J, Canals M et al (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1–A2A Receptor Heteromers. J Neurosci [Internet] 26(7):2080–2087. https://doi.org/10.1523/JNEUROSCI.3574-05.2006
doi: 10.1523/JNEUROSCI.3574-05.2006
Cristóvão-Ferreira S, Navarro G, Brugarolas M, Pérez-Capote K, Vaz SH, Fattorini G, et al. (2013) A1R–A2AR heteromers coupled to Gs and G i/o proteins modulate GABA transport into astrocytes. Purinergic Signal [Internet]. 9(3):433–49. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3757138&tool=pmcentrez&rendertype=abstract
Hinz S, Navarro G, Borroto-Escuela D, Seibt BF, Ammon C, Filippo E De, et al. (2018) Adenosine A2A receptor ligand recognition and signaling is blocked by A2B receptors. Oncotarget [Internet]. 9(17):13593–611. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29568380
Gao ZG, Inoue A, Jacobson KA (2018) On the G protein-coupling selectivity of the native A2B adenosine receptor. Biochem Pharmacol 1(151):201–213
doi: 10.1016/j.bcp.2017.12.003
Yang X, Xin W, Yang X-M, Kuno A, Rich TC, Cohen MV et al (2011) A
doi: 10.1111/j.1476-5381.2011.01288.x
Gnad T, Scheibler S, Kugelgen I Von, Scheele C, Kilic A, Glode A, et al. (2014) Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors. Nature [Internet]. 516(7531):395–9. Available from: https://www.nature.com/articles/nature13816
Lahesmaa M, Oikonen V, Helin S, Luoto P, DinPfeifer UMA et al (2019) Regulation of human brown adipose tissue by adenosine and A 2A receptors—studies with [15 O]H 2 O and [11 C]TMSX PET/CT. Eur J Nucl Med Mol Imaging [Internet] 46(3):743–750. https://doi.org/10.1007/s00259-018-4120-2
doi: 10.1007/s00259-018-4120-2
Ruan CC, Kong LR, Chen XH, Ma Y, Pan XX, Zhang ZB et al (2018) A2A receptor activation attenuates hypertensive cardiac remodeling via promoting brown adipose tissue-derived FGF21. Cell Metab 28(3):476-489.e5
doi: 10.1016/j.cmet.2018.06.013
Lillo A, Martínez-Pinilla E, Reyes-Resina I, Navarro G, Franco R (2020) Adenosine A2a and A3 receptors are able to interact with each other. A further piece in the puzzle of adenosine receptor-mediated signaling. Int J Mol Sci [Internet]. 21(14):1–14. Available from: https://www.mdpi.com/1422-0067/21/14/5070?utm_source=researcher_app&utm_medium=referral&utm_campaign=RESR_MRKT_Researcher_inbound
Hill SJ, May LT, Kellam B, Woolard J (2014) Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerization. Br J Pharmacol [Internet]. 171(5):1102–13. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3952791&tool=pmcentrez&rendertype=abstract

Auteurs

Rafael Franco (R)

Molecular Neurobiology Laboratory, Department Biochemistry and Molecular Biomedicine, School of Biology, University of Barcelona, Diagonal 643, Catalonia, 08028, Barcelona, Spain. rfranco123@gmail.com.
Centro de Investigación en Red, Enfermedades Neurodegenerativas (CiberNed), Instituto de Salud Carlos iii, Madrid, Spain. rfranco123@gmail.com.

Arnau Cordomí (A)

Laboratori de Medicina Computacional, Unitat de Bioestadística, Facultat de Medicina, Universitat Autònoma de Barcelona, Campus Universitari, 08193, Bellaterra (Barcelona), Spain.

Claudia Llinas Del Torrent (C)

Laboratori de Medicina Computacional, Unitat de Bioestadística, Facultat de Medicina, Universitat Autònoma de Barcelona, Campus Universitari, 08193, Bellaterra (Barcelona), Spain.

Alejandro Lillo (A)

Department of Biochemistry and Physiology, School of Pharmacy and Food Science, University of Barcelona, Catalonia, Barcelona, Spain.

Joan Serrano-Marín (J)

Molecular Neurobiology Laboratory, Department Biochemistry and Molecular Biomedicine, School of Biology, University of Barcelona, Diagonal 643, Catalonia, 08028, Barcelona, Spain.

Gemma Navarro (G)

Centro de Investigación en Red, Enfermedades Neurodegenerativas (CiberNed), Instituto de Salud Carlos iii, Madrid, Spain.
Department of Biochemistry and Physiology, School of Pharmacy and Food Science, University of Barcelona, Catalonia, Barcelona, Spain.

Leonardo Pardo (L)

Laboratori de Medicina Computacional, Unitat de Bioestadística, Facultat de Medicina, Universitat Autònoma de Barcelona, Campus Universitari, 08193, Bellaterra (Barcelona), Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH